Literature DB >> 11458340

Quantification of pore induction in human epidermal membrane during iontophoresis: the importance of background electrolyte selection.

H Zhu1, K D Peck, S K Li, A H Ghanem, W I Higuchi.   

Abstract

It has been shown that significant pore induction (electroporation) occurs in human epidermal membrane (HEM) during iontophoresis even at moderate applied voltages (1-10 V). Recent efforts in our laboratory have been aimed at quantifying HEM electroporation by examining the proportionality between flux enhancement due to electroporation and electrical conductance changes during iontophoresis. The specific purpose of the present study was to test the hypothesis that by matching the background electrolyte ion sizes with the permeant ion sizes, the flux enhancement due to electroporation can be quantified by the change in HEM electrical conductance. In this study, radiolabeled tetraethylammonium (TEA(+)), methylammonium (MA(+)), and mannitol were the permeants. Potassium chloride (KCl), tetraethylammonium bromide (TEAB), tetraethylammonium pivalate (TEAP), and sodium fluoride (NaF) were the background electrolytes. Iontophoresis experiments were carried out over an applied voltage range of 1 to 3 V. The experimental flux enhancement results were compared with the theoretical predictions from the Nernst-Planck model after corrections were made: (a) for HEM pore induction during iontophoresis based on electrical conductance changes and (b) for electroosmosis employing mannitol as the neutral probe permeant. In experiments where the ion sizes of the background electrolyte and permeant were closely matched (e.g., TEA(+) as the permeant and TEAP as the background electrolyte), there was excellent agreement between experimental results and theoretical predictions of the modified Nernst-Planck model, with only modest data scatter. When the electrolyte and permeant sizes were quite different (e.g., TEA(+)/KCl and MA(+)/TEAP), the experimental flux data were inconsistent with model predictions and there were large variations in the experimental results. The results of the present study illustrate that permeant flux enhancement can be predicted by the modified Nernst-Planck model even during moderate voltage iontophoresis when electroporation is operative.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11458340     DOI: 10.1002/jps.1044

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  7 in total

1.  Effects of organic solvents on the barrier properties of human nail.

Authors:  Kelly A Smith; Jinsong Hao; S Kevin Li
Journal:  J Pharm Sci       Date:  2011-05-23       Impact factor: 3.534

2.  Iontophoretic transport across a multiple membrane system.

Authors:  Sarah A Molokhia; Yanhui Zhang; William I Higuchi; S Kevin Li
Journal:  J Pharm Sci       Date:  2008-01       Impact factor: 3.534

3.  Influence of pH on transungual passive and iontophoretic transport.

Authors:  Kelly A Smith; Jinsong Hao; S Kevin Li
Journal:  J Pharm Sci       Date:  2010-04       Impact factor: 3.534

4.  Mechanistic study of electroosmotic transport across hydrated nail plates: effects of pH and ionic strength.

Authors:  Jinsong Hao; S Kevin Li
Journal:  J Pharm Sci       Date:  2008-12       Impact factor: 3.534

5.  Alternating current (AC) iontophoretic transport across human epidermal membrane: effects of AC frequency and amplitude.

Authors:  Guang Yan; Qingfang Xu; Yuri G Anissimov; Jinsong Hao; William I Higuchi; S Kevin Li
Journal:  Pharm Res       Date:  2007-08-17       Impact factor: 4.200

6.  Transungual iontophoretic transport of polar neutral and positively charged model permeants: effects of electrophoresis and electroosmosis.

Authors:  Jinsong Hao; S Kevin Li
Journal:  J Pharm Sci       Date:  2008-02       Impact factor: 3.534

7.  Chemical method to enhance transungual transport and iontophoresis efficiency.

Authors:  Jinsong Hao; Kelly A Smith; S Kevin Li
Journal:  Int J Pharm       Date:  2008-01-20       Impact factor: 5.875

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.